Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 1,026–1,050 of 27,380 studies, newest first · page 42 of 1096.

July 2026 14

  1. 2026-07-01

    ENHANCED ALZHEIMER DISEASE DIAGNOSIS THROUGH DEEP LEARNING-BASED MRI SEGMENTATION AND CLASSIFICATION

    ✓ Peer-reviewed Brain scans and imaging RCHUB JOURNAL OF COMPUTATIONAL INTELLIGENCE SCIENCE AND ENGINEERING (JCISE)

    Key finding: MRI has become an effective modality for analyzing the brain structure, which offers a detailed insights into the pathological regions that is associated with the AD. +1 more finding

  2. 2026-07-01

    Amyloid probability in Alzheimer disease from plasma, cerebrospinal fluid, and amyloid imaging

    ✓ Peer-reviewed Brain scans and imaging npj Dementia

    Key finding: Blood-based biomarkers are increasingly used to triage patients for amyloid confirmation, yet performance is often reported versus a single comparator despite discordance between amyloid PET and CSF.

  3. 2026-07-01

    Towards an Equitable Approach to Multilingual Language Assessment in Dementia Care

    ✓ Peer-reviewed Getting a diagnosis Topics in Language Disorders

    Key finding: Health disparities in dementia care are amplified among aging multilingual communities relative to their monolingual English-speaking counterparts, as social determinants of health and significant gaps in culturally responsive practice can contribute to misdiagnosis, underdiagnosis, and delays in intervention. +1 more finding

  4. 2026-07-01

    CD33 and clusterin interact biophysically and genetically to modulate Alzheimer risk

    ✓ Peer-reviewed Genetics DOAJ (DOAJ: Directory of Open Access Journals)

    Key finding: We show that CD33M ectodomain dimerizes, enabling binding of large multi-sialylated molecules.

  5. 2026-07-01

    Recent breakthroughs in blood-based biomarkers of Alzheimer disease: opportunities and challenges in older adults

    ✓ Peer-reviewed Biomarkers Age and Ageing

    Key finding: Across multiple analytical platforms, plasma p-tau217 has demonstrated consistently strong diagnostic performance for the detection of amyloid pathology. +1 more finding

  6. 2026-07-01

    Loneliness Moderates the Association between Neighborhood Disadvantage and Cognitive Function Among Older Adults

    ✓ Peer-reviewed Risk factors Delaware Journal of Public Health

    Key finding: Loneliness moderated the relationship between national ADI scores and short-term visuospatial memory. +4 more findings

  7. 2026-07-01

    [Consistency evaluation of the domestic Lifotronic platform and foreign luminescence platforms in detecting core cerebrospinal fluid biomarkers in Chinese Alzheimer disease patients]

    ✓ Peer-reviewed Tau biomarkers Zhonghua yi xue za zhi

    Key finding: CSF samples were retrospectively collected from 253 subjects recruited at Peking Union Medical College Hospital, Xuanwu Hospital Capital Medical University, and Beijing Tiantan Hospital between July 2013 and September 2019. +3 more findings

  8. 2026-07-01

    Plasma Phosphorylated Tau 217 in Participants at Risk for Chronic Traumatic Encephalopathy

    ✓ Peer-reviewed Tau biomarkers JAMA network open

    Key finding: In vivo biomarkers for detecting neuropathologies from repetitive head impacts (RHI), including chronic traumatic encephalopathy (CTE), are needed. +3 more findings

  9. 2026-07-01

    Early Alzheimer´s disease blood biomarkers are associated with a higher risk for postoperative long-term cognitive decline: Insights from the FINDERI study

    ✓ Peer-reviewed Tau biomarkers Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: The study aim is to investigate whether blood biomarkers (BBMs) of Alzheimer's disease (AD) pathology are associated with postoperative cognitive dysfunction (POCD) after cardiac surgery. +3 more findings

  10. 2026-07-01
  11. 2026-07-01

    The tau biomarker cascade is condensed in Down syndrome compared with sporadic Alzheimer's disease

    ✓ Peer-reviewed Down syndrome and Alzheimer's Brain : a journal of neurology

    Key finding: Individuals with DS had a significantly higher lifetime risk of beta-amyloid plaque onset. +1 more finding

  12. 2026-07-01

    Plasma eMTBR-tau243 and %p-tau217 for Biological Staging of Alzheimer Disease

    ✓ Peer-reviewed Biomarkers JAMA Neurology

    Key finding: The BioFINDER-2 main cohort included 872 participants, with an additional 156 participants in the Knight ADRC cohort for independent validation. +1 more finding

  13. 2026-07 month only

    APOE-ε4 carriership and dementia risk over 10 years among Asian American and White older adults

    ✓ Peer-reviewed Genetics Alzheimer's & Dementia

    Key finding: Despite differences in prevalence of APOE-ε4, its association with dementia risk was similar across Chinese, Japanese, Filipino, and non-Latino White participants. +1 more finding

  14. 2026-07-01

    Genetic Risk for Alzheimer Disease, Midlife Hypertension, and Dementia: The ARIC Neurocognitive Study

    ✓ Peer-reviewed Genetics Neurology

    Key finding: Genetic risk for AD does not modify the association between hypertension and dementia. +3 more findings

June 2026 11

  1. 2026-06-30

    Functional–behavioral patterns associated with care-related risk in hospitalized patients with Alzheimer’s disease: a real-world clustering analysis

    ⚠ Preprint — not yet peer-reviewed Clinical safety Research Square

    Key finding: Functional–behavioral subtypes can be identified in hospitalized AD patients, supporting multidimensional risk stratification and individualized care planning. +1 more finding

    Scored 35 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  2. 2026-06-30

    How and why adult day programs influence admissions to long-term care homes for persons living with dementia: A program theory based on a realist review

    ⚠ Preprint — not yet peer-reviewed Health systems and care delivery Research Square

    Key finding: Contexts and mechanisms associated with attendees’ and caregivers’ social determinants of health, and system-level contexts and mechanisms that influence ADPs are important knowledge gaps to be addressed by studies and to be incorporated in our program theory in the future. +2 more findings

    Scored 27 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  3. 2026-06-30

    Neuroinflammation and Tauopathies

    ✓ Peer-reviewed Inflammation and the immune system Molecular biology reports

    Key finding: This review combines current knowledge on the molecular and cellular mechanisms linking Tau pathology to chronic neuroinflammatory signaling, with a particular focus on microglia- and astrocyte-mediated responses. +4 more findings

  4. 2026-06-30

    The Silent Crisis: Loneliness in Older Adults-A Critical Review of Impacts, Strategies and Path Forward

    ✓ Peer-reviewed Health systems and care delivery Scandinavian journal of caring sciences

    Key finding: Mechanisms include increased inflammation (↑CRP, IL-6), HPA dysregulation, immune compromise, hippocampal atrophy, and behavioural lapses. +4 more findings

  5. 2026-06-30

    Exossomos, Neuroinflamação e Biomarcadores Hematológicos na Doença de Alzheimer: revisão Sistemática

    ✓ Peer-reviewed Tau biomarkers Revista Educação em Saúde/Revista Educação em Saúde Unievangélica

    Key finding: Foram incluídos artigos originais e revisões publicados nos últimos 10 anos, em inglês, português ou espanhol, relacionados a exossomos neuronais, biomarcadores hematológicos, neuroinflamação e nanotecnologia aplicada à DA. +4 more findings

  6. 2026-06-30

    Therapeutic monoclonal antibodies targeting amyloid beta in Alzheimer disease current evidence clinical outcomes limitations and future directions

    ✓ Peer-reviewed Treatments Discover Neuroscience

    Key finding: Recent regulatory approvals of aducanumab, lecanemab, and donanemab demonstrate significant plaque reduction and modest slowing of cognitive decline in early AD, supporting the amyloid hypothesis.

  7. 2026-06-30

    PET Imaging in Alzheimer Disease: Diagnostic and Prognostic Applications

    ✓ Peer-reviewed Biomarkers International Journal of Clinical and Medical Research

    Key finding: Evidence indicates that amyloid PET is highly useful for establishing amyloid pathology, whereas tau PET is more closely associated with disease stage and clinical severity.

  8. 2026-06-29

    Transitional care needs of persons with dementia and their care partners: a secondary analysis using Transitions Theory

    ⚠ Preprint — not yet peer-reviewed End-of-life care medRxiv

    Key finding: When tailored transitional care guidance is lacking, care partners must take on significant responsibility for finding information and making decisions.

    Scored 27 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  9. 2026-06-29

    Anti-amyloid immunotherapy drives APOE4 specific increases in glial reactivity, perivascular immune activation, and ARIA-like events

    ⚠ Preprint — not yet peer-reviewed Treatments bioRxiv

    Key finding: E4FAD mice demonstrated plaque reductions with accompanying increases in microhemorrhages (measured on both MRI and histology), and increases in microglial and astrocyte reactivity - especially in the perivascular compartment. +2 more findings

    Scored 21 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  10. 2026-06-29

    Oral Microbiome and Its Emerging Role in Alzheimer\'s Disease: A Comprehensive Review

    ✓ Peer-reviewed Treatments Journal of Acute Care Trauma and Emergency Medicine

    Key finding: Alzheimer's disease (AD) affects ~55 million people globally and is projected to rise steeply with population ageing.

  11. 2026-06-29

    Prior Traumatic Brain Injury and Alzheimer Disease Blood Biomarkers

    ✓ Peer-reviewed Biomarkers JAMA Neurology

    Key finding: In 272 participants, mean (SD) age was 70 (4.5) years, 270 were male (99.3%), and 83 (30.5%) were amyloid-PET positive. +4 more findings

Browse the library by subject, with the full score breakdown →